lipofectamine and Hemolysis

lipofectamine has been researched along with Hemolysis* in 2 studies

Other Studies

2 other study(ies) available for lipofectamine and Hemolysis

ArticleYear
Novel endosomolytic peptides for enhancing gene delivery in nanoparticles.
    Biochimica et biophysica acta, 2015, Volume: 1848, Issue:2

    Trapping in the endosomes is currently believed to represent the main barrier for transfection. Peptides, which allow endosomal escape have been demonstrated to overcome this barrier, similarly to the entry of viruses. However, the design principles of such endosomolytic peptides remain unclear. We characterized three analogs derived from membrane disrupting antimicrobial peptides (AMP), viz. LL-37, melittin, and bombolitin V, with glutamic acid substituting for all basic residues. These analogs are pH-sensitive and cause negligible membrane permeabilization and insignificant cytotoxicity at pH7.4. However, at pH5.0, prevailing in endosomes, membrane binding and hemolysis of human erythrocytes become evident. We first condensed the emerald green fluorescent protein (emGFP) containing plasmid by protamine, yielding 115 nm diameter soluble nanoplexes. For coating of the nanoplex surface with a lipid bilayer we introduced a hydrophobic tether, stearyl-octa-arginine (SR8). The indicated peptides were dissolved in methanol and combined with lipid mixtures in chloroform, followed by drying at RT under a nitrogen flow. The dry residues were hydrated with nanoplexes in Hepes, pH7.4 yielding after a 30 min incubation at RT,rather monodisperse nanoparticles having an average diameter of 150-300 nm, measured by DLS and cryo-TEM. Studies with cell cultures showed the above peptides to yield expression levels comparable to those obtained using Lipofectamine 2000. However, unlike the polydisperse aggregates formed upon mixing Lipofectamine 2000 and plasmid, the procedure described yields soluble, and reasonably monodisperse nanoparticles, which can be expected to be suitable for gene delivery in vivo, using intravenous injection.

    Topics: Amino Acid Sequence; Animals; Antimicrobial Cationic Peptides; Cathelicidins; Endosomes; Erythrocytes; Gene Expression; Glutamic Acid; Green Fluorescent Proteins; Hemolysis; Humans; Hydrogen-Ion Concentration; Lipids; Melitten; Mice; Molecular Sequence Data; Nanoparticles; NIH 3T3 Cells; Oligopeptides; Particle Size; Peptides; Protamines; Stearates; Transfection

2015
Selective blocking of primary amines in branched polyethylenimine with biocompatible ligand alleviates cytotoxicity and augments gene delivery efficacy in mammalian cells.
    Colloids and surfaces. B, Biointerfaces, 2014, Mar-01, Volume: 115

    Recently, polyethylenimines (PEIs) have emerged as efficient vectors for nucleic acids delivery. However, inherent cytotoxicity has limited their in vivo applications. To address this concern as well as to incorporate hydrophobic domains for improving interactions with the lipid bilayers in the cell membranes, we have tethered varying amounts of amphiphilic pyridoxyl moieties onto bPEI to generate a small series of pyridoxyl-PEI (PyP) polymers. Spectroscopic characterization confirms the formation of PyP polymers, which subsequently form stable complexes with pDNA in nanometric range with positive surface charge. The projected modification not only accounts for a decrease in the density of 1° amines but also allows formation of relatively loose complexes with pDNA (cf. bPEI). Alleviation of the cytotoxicity, efficient interaction with cell membranes and easy disassembly of the pDNA complexes have led to the remarkable enhancement in the transfection efficiency of PyP/pDNA complexes in mammalian cells with one of the formulations, PyP-3/pDNA complex, showing transfection in ∼68% cells compared to ∼16% cells by Lipofectamine/pDNA complex. Further, the efficacy of PyP-3 vector has been established by delivering GFP-specific siRNA resulting in ∼88% suppression of the target gene expression. These results demonstrate the efficacy of the projected carriers that can be used in future gene therapy applications.

    Topics: Amines; Biocompatible Materials; Buffers; Cell Death; Cell Survival; Deoxyribonuclease I; DNA; Fluorescence; Gene Transfer Techniques; Green Fluorescent Proteins; HeLa Cells; Hemolysis; Heparin; Humans; Ligands; Lipids; MCF-7 Cells; Nuclease Protection Assays; Particle Size; Plasmids; Polyethyleneimine; RNA, Small Interfering; Static Electricity; Titrimetry

2014